Clinical Trials Logo

Clinical Trial Summary

Nosocomial pneumonia is the third causes of nosocomial infection. In intensive care unit, their incidence is even higher, of the order of 10 to 30% in patients with invasive mechanical ventilation (IMV). One of the main mechanisms behind VAP (Ventilator-Associated Pneumonia) is the passage of germs colonizing the oropharynx to the subglottic airways. The presence of a nasogastric tube, immobilization, and strict dorsal decubitus increase the risk of colonization of the tracheobronchial tree and pneumonia in these patients. To reduce the incidence of VAP, several strategies have been developed in intensive care to try to control these different risk factors. These sets of measures, also called "bundle" systematically include the control of the elevation of the patient's head more than 30 °. Nevertheless, the strict and permanent control of the elevation of the patient's head is difficult to obtain. One of the reasons that may explain the difficulty of ensuring a correct elevation is the absence of visual cues that are easy to obtain on the beds of patients. An easily identifiable visual cue at the head of the bed would probably provide a satisfactory elevation (greater than 30 °) in patients intubated in intensive care. Our hypothesis is that the addition to the head of the patient's bed of a visible mark that is easily visible and easily interpretable by all the nurses will improve the elevation of the head of the patients in intensive care.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03687177
Study type Interventional
Source University Hospital, Strasbourg, France
Contact Sylvie L'HOTELLIER
Phone 03.88.12.79.14
Email sylvie.l'hotellier@chru-strasbourg.fr
Status Recruiting
Phase N/A
Start date September 20, 2018
Completion date October 22, 2019

See also
  Status Clinical Trial Phase
Completed NCT03995030 - Massively Parallel Sequencing to Identify Microbiological Organisms in Bronchoalveolar Lavage Fluid
Recruiting NCT05552872 - Study on Diagnosis Value of mNGS Technology Among Diabetic Patients With Pulmonary Infections
Not yet recruiting NCT04583046 - Effects of Iloprost on Pulmonary Oxygenation in Obese Patients During One-lung Ventilation N/A
Recruiting NCT04624490 - Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease Phase 1
Recruiting NCT05505487 - Construction and Effect Evaluation of Integrated Care Model for Pulmonary Infection in Stroke Patients With Tracheotomy N/A
Terminated NCT04348513 - Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection Phase 2
Completed NCT03438383 - Bi-PAP vs Sham Bi-PAP on Pulmonary Function in Morbidly Obese Patients After Bariatric Surgery N/A
Completed NCT03933878 - Rapid Detection of Airway Pathogens for Lung Transplantation
Completed NCT05844215 - MMP-9, TIMP-9 in Lung Imaging and Functional of COVID-19
Completed NCT02779595 - Change of Regional Ventilation During Spontaneous Breathing After Lung Surgery N/A
Recruiting NCT06368388 - Bacteriophage Therapy for Difficult-to-treat Infections: the Implementation of a Multidisciplinary Phage Task Force
Recruiting NCT04457609 - Administration of Allogenic UC-MSCs as Adjuvant Therapy for Critically-Ill COVID-19 Patients Phase 1
Completed NCT01525121 - Expiratory Rib Cage Compression in Mechanically Ventilated Patients N/A
Active, not recruiting NCT03617393 - Study on Appropriate Technology of Standardized Diagnosis and Treatment for Diabetic Patients With Pulmonary Infections
Completed NCT05226403 - COVID-19 : Pulmonary Ultrasound in Primary Care
Terminated NCT04422691 - Ultrasonography in Norwegian Emergency Department Patients With Suspected Covid-19 Infection
Completed NCT04553315 - the Effect of Chest Expansion Exercises on Pleural Effusion N/A
Recruiting NCT06282835 - Eravacycline Combination Therapy for MRAB
Completed NCT02419196 - Perioperative Change of Regional Ventilation During Spontaneous Breathing N/A
Completed NCT01058356 - Effect of Probiotic Lactobacilli (Lacidofil Cap®) for the Prevention of Antibiotic-Associated Diarrhea N/A